A new compound developed by University of Sheffield experts has killed antibiotic-resistant gram-negative bacteria, including E. coli, during tests
- New treatments for gram-negative bacteria are vital as they are rapidly becoming immune to current drugs
- Antimicrobial resistance is already responsible for 25,000 deaths in the EU each year
- The research could pave the way for new treatment of life-threatening superbugs
A new compound which visualises and kills antibiotic-resistant superbugs has been discovered by scientists at the University of Sheffield and the Science and Technology Facilities Council (STFC).
The team, led by Professor Jim Thomas, from the University of Sheffield’s Department of Chemistry, is testing new compounds developed by his PhD student Kirsty Smitten on antibiotic resistant gram-negative bacteria, including pathogenic E. coli.
Gram-negative bacteria strains can cause infections including pneumonia, urinary tract infections and bloodstream infections. They are difficult to treat as the cell wall of the bacteria prevents drugs from getting into the microbe.
Antimicrobial resistance is already responsible for 25,000 deaths in the EU each year, and unless this rapidly emerging threat is addressed, it’s estimated by 2050 more than 10 million people could die every year due to antibiotic resistant infections.
Doctors have not had a new treatment for gram-negative bacteria in the last 50 years, and no potential drugs have entered clinical trials since 2010.
The new drug compound has a range of exciting opportunities. As Professor Jim Thomas explains: “As the compound is luminescent it glows when exposed to light. This means the uptake and effect on bacteria can be followed by the advanced microscope techniques available at STFC’s Central Laser Facility (CLF).
“This breakthrough could lead to vital new treatments to life-threatening superbugs and the growing risk posed by antimicrobial resistance.”
The studies at Sheffield and CLF have shown the compound seems to have several modes of action, making it more difficult for resistance to emerge in the bacteria. The next step of the research will be to test it against other multi-resistant bacteria.
In a recent report on antimicrobial resistant pathogens, the World Health Organisation put several gram-negative bacteria at the top of its list, stating that new treatments for these bacteria were ‘Priority 1 Critical’ because they cause infections with high death rates, are rapidly becoming resistant to all present treatments and are often picked up in hospitals.
The Latest on: Antibiotic-resistant superbugs
via Google News
The Latest on: Antibiotic-resistant superbugs
- Turning to dirt for antibiotics in the fight against superbugson October 6, 2020 at 1:28 am
Dirt contains an entire microbial ecosystem, with a wealth of intriguing compounds. And while there are major hurdles between discovering a new drug and using it, scientists are hopeful new techniques ...
- Antibiotic-resistant “superbug” detected South Korea raw squidon October 3, 2020 at 5:00 pm
A dangerous antibiotic-resistant “superbug” has been found in the North American food supply for the first time, according to researchers from the University of Saskatchewan. The unwelcome ...
- While the world is gripped by COVID-19, another devastating health threat is building — this one from bacteriaon October 1, 2020 at 9:27 am
Diseases caused by bacteria already kill 700,000 people every year. The threat is slowly growing, with few ways to stop it.
- Bacterial ‘superbug’ popping up in nation’s health facilitieson September 30, 2020 at 5:00 pm
Through a coordinated effort, we can ensure the health and safety of patients by staving off the spread of antibiotic-resistant superbugs like CRE, save health-care dollars, and most important ...
- Recce Pharmaceuticals and Murdoch Children’s Research Institute to Evaluate RECCE® 435 Against ...on September 30, 2020 at 5:53 am
Murdoch Children’s Research Institute to evaluate the in-vivo antimicrobial activity of RECCE® 435 oral formulation against Helicobacter pylori (H. pylori) in preclinical studies program Studies led ...
- CPE superbug being detected at record levels, says HSEon September 30, 2020 at 4:48 am
August was the worst month yet for detections of an antibiotic-resistant superbug said to pose an “existential threat” to the health service. Monitoring saw 97 new patients diagnosed with ...
- Australia’s Recce raises AU$28 million to advance new class of synthetic anti-infectiveson September 28, 2020 at 5:00 pm
PERTH, Australia – Sydney-based Recce Pharmaceuticals Ltd. completed a placement of AU$27.95 million (US$19.69 million) to advance its synthetic anti-infective pipeline to address antibiotic-resistant ...
- Key genetic clue missing in fight against superbugson September 24, 2020 at 7:25 am
Researchers say it is critical that plasmids are included when tracking antibiotic resistance in order to have the best chance of stopping superbugs ... rise in antibiotic resistant bacterial ...
via Bing News